ICC Labs Inc. (ICC) Analysts See $-0.01 EPS

May 17, 2018 - By Dolores Ford

Analysts expect ICC Labs Inc. (CVE:ICC) to report $-0.01 EPS on May, 29.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.01 EPS. The stock decreased 2.19% or $0.03 during the last trading session, reaching $1.34. About 76,382 shares traded. ICC Labs Inc. (CVE:ICC) has 0.00% since May 17, 2017 and is . It has underperformed by 11.55% the S&P500.

ICC Labs Inc. produces and sells cannabis in Uruguay. The company has market cap of $184.98 million. It offers recreational cannabis, cannabinoid extracts, and by-products for medicinal use, as well as industrial hemp. It currently has negative earnings. The firm was formerly known as ICC International Cannabis Corporation and changed its name to ICC Labs Inc. in December 2017.

Another recent and important ICC Labs Inc. (CVE:ICC) news was published by Midasletter.com which published an article titled: “Canada Cannabis Roundup: ICC Labs, Choom, Delta 9 Cannabis, Hiku, WeedMD, Indiva, Golden Leaf Holdings” on April 19, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.